Monday, May 27, 2024

Alzheimer’s vaccine licensing deal boosts AC Immune

Must read




AC Immune shares jumped more than 50% premarket on Monday after the company announced a licensing deal with Takeda Pharmaceutical Co. for its experimental Alzheimer’s disease vaccine.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article